Trial Profile

A randomized, double-blind, placebo-controlled, Phase 1 trial assessing safety and tolerability of VK2735 administered as an oral tablet in healthy adults

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 07 Feb 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs VK 2735 (Primary)
Indications Diabetes mellitus; Non-alcoholic steatohepatitis; Obesity
Focus Adverse reactions

Most Recent Events

25 Oct 2023 According to Viking Therapeutics media release, results expected in 1Q24.
26 Jul 2023 According to a Viking Therapeutics media release, the company expects to report initial data of this trial in 4Q23.
04 Apr 2023 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com